Innoviz Technologies Ltd. INVZ
0.39
0.02
5.41%
as of 25 Sep
- Market cap
- $116.3M
- P/E
- 0.0×
Follow INVZ
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
3.21 | 3.03 | 3.08 | 8.57 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(11.88) | (9.40) | (18.61) | (30.23) | |
P/B ratio |
3.51 | 2.28 | 2.19 | 4.63 | |
Price to Tangible BV |
3.51 | 2.28 | 2.19 | 4.63 | |
EV/Sales |
2.89 | 2.39 | 2.35 | 7.68 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(2.98) | (2.46) | (2.70) | (6.57) | |
EV/FCF |
(2.94) | (2.41) | (2.62) | (6.10) | |
Quick Ratio |
1.49 | 1.92 | 2.61 | 2.93 | |
Current Ratio |
1.73 | 2.21 | 2.87 | 3.18 | |
Net Debt/EBITDA |
2.82 | 2.39 | 3.77 | 5.15 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.39 | 0.32 | 0.41 | 0.33 | |
Operating CF/Net income |
0.78 | 0.55 | 0.43 | 0.89 | |
Capex/Depreciation |
(0.69) | (1.02) | 1.04 | (0.21) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
64.70% | 234.92% | 127.22% | 80.98% | |
Selling, General and Administrative Expense of Revenue |
41.01% | 114.01% | 54.19% | 37.47% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
21.93% | 52.04% | 32.38% | 25.81% | |
Graham Net Nets |
0.01 | 0.09 | 0.17 | 0.10 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(50.00%) | (61.90%) | (40.00%) | (17.16%) | |
Free Cash Flow Yield |
(30.64%) | (32.69%) | (28.99%) | (14.69%) | |
Revenue per Share |
0.08 | 0.03 | 0.06 | 0.08 | |
Operating CF per Share |
(0.06) | (0.07) | (0.05) | (0.07) | |
Capex per Share |
0.00 | (0.01) | 0.01 | 0.00 | |
Free Cash Flow per Share |
(0.07) | (0.07) | (0.04) | (0.07) | |
Cash per Share |
0.22 | 0.28 | 0.36 | 0.37 | |
Shareholders Equity per Share |
0.22 | 0.28 | 0.39 | 0.44 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.22 | 0.28 | 0.39 | 0.44 | |
Free Cash Flow |
(15.23) | (15.80) | (7.26) | (14.01) | |
Working Capital |
30.59 | 41.04 | 58.81 | 70.09 | |
Capital Expenditures |
(0.86) | (1.35) | 1.88 | (0.29) | |
Net Current Asset Value |
1.37 | 12.53 | 29.50 | 40.80 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.19 | (0.15) | 0.02 | |
Net Profit Margin |
(102.45%) | (367.29%) | (167.71%) | (100.92%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
12.70 | 11.48 | 8.01 | 11.68 | |
Average Payables |
9.08 | 7.59 | 8.71 | 7.85 | |
Average Inventory |
4.28 | 2.79 | 2.62 | 2.10 | |
Average Assets |
135.42 | 139.65 | 135.25 | 147.72 | |
Average Common Equity |
70.91 | 83.71 | 78.32 | 91.15 |
Columns are period end dates